NIDAN

Nidan Laboratories And Healthcare Share PriceNidan Laboratories And Healthcare

₹42.15
-0.35 (-0.82%)
As on 28 May, 2023 | 11:19 BSE: NSE: NIDAN

Nidan Laboratories And Healthcare Performance

Day Range

  • Low
  • High
42.15

52 Week Range

  • Low
  • High
42.15
  • Open Price
  • Previous Close
  • Volume

Start SIP in Nidan Laboratories And Healthcare

Start SIP

Nidan Laboratories And Healthcare Share Price

  • Over 1 Month 1.93%
  • Over 3 Month -8.67%
  • Over 6 Month -20.4%
  • Over 1 Year 14.85%

Nidan Laboratories And Healthcare Key Statistics

P/E Ratio
PEG Ratio
Market Cap Cr 59
Price to Book Ratio 0.9
EPS 1.8
Dividend 0
Relative Strength Index 50.16
Money Flow Index 27.81
MACD Signal 0.3
Average True Range 1.47

Nidan Laboratories And Healthcare Investment Rating

  • Master Rating:
  • Nidan Laboratories And Healthcare has an operating revenue of Rs. 93.24 Cr. on a trailing 12-month basis. An annual revenue growth of 40% is outstanding, Pre-tax margin of 15% is great, ROE of 4% is fair but needs improvement. The company has a reasonable debt to equity of 14%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 42 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 149 indicates it belongs to a poor industry group of Medical-Services and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

N/A

Price Strength

Buyer Demand

Group Rank

Nidan Laboratories And Healthcare Financials
IndicatorMar 2022
Total Revenue Annual Cr 30
Operating Expenses Annual Cr 20
Operating Profit Annual in Cr 9
Depreciation Cr 3
Interest Annual Cr 3
Tax Annual Cr 2
Net Profit Annual Cr 3

Nidan Laboratories And Healthcare Technicals

EMA & SMA

Current Price
₹42.15
-0.35 (-0.82%)
  • Bullish Moving Average
  • ___
  • 4
  • Bearish Moving Average
  • ___
  • 12
  • 20 Day
  • ₹42.2
  • 50 Day
  • ₹42.52
  • 100 Day
  • ₹44.27
  • 200 Day
  • ₹46.37
  • 20 Day
  • ₹42.61
  • 50 Day
  • ₹41.17
  • 100 Day
  • ₹44.74
  • 200 Day
  • ₹48.45

Nidan Laboratories And Healthcare Resistance and Support

PIVOT
₹42.65
Resistance
First Resistance ₹43.3
Second Resistance ₹44.1
Third Resistance ₹44.75
RSI 50.16
MFI 27.81
MACD Single Line 0.3
MACD 0.21
Support
First Resistance ₹41.85
Second Resistance ₹41.2
Third Resistance ₹40.4

Nidan Laboratories And Healthcare Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 3,000 300,000 100
Week 4,600 400,016 86.96
1 Month 6,550 539,982 82.44
6 Month 10,385 765,600 73.72

Nidan Laboratories And Healthcare Result Highlights

Nidan Laboratories And Healthcare Synopsis

NSE-Medical-Services

Nidan Laboratories is involved in the business activities of Other Hospital and Medical Care Activities. Company’s Total Operating Revenue is Rs. 29.66 Cr. and Equity Capital is Rs. 13.90 Cr. for the Year ended 31/03/2022. Nidan Laboratories And Healthcare Ltd. is a Public Limited Listed company incorporated on 05/12/2000 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is U33111MH2000PLC129883 and registration number is 129883.
Market Cap 59
Sales 30
Shares in Float 0.40
No of funds
Yield
Book Value 0.89
U/D Vol ratio 0.3
LTDebt / Equity 14
Alpha 0.14
Beta 0.87

Nidan Laboratories And Healthcare

Owner NameMar-23Sep-22
Promoters 71.22%71.22%
Individual Investors 26.62%
Others 2.16%28.78%

Nidan Laboratories And Healthcare Management

Name Designation
Mr. Edwin Francis Dabre Executive Director
Mrs. Tejal Anil Jayakar Executive Director & CFO
Mr. Krupesh Deepak Thakur Non Executive Director
Mr. Nilesh Ghanshyam Bide Ind. Non-Executive Director
Mr. Abhinay Shashikant Nerurkar Ind. Non-Executive Director
Mr. Karim Hakam Khimani Ind. Non-Executive Director

Nidan Laboratories And Healthcare Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Nidan Laboratories And Healthcare Corporate Action

Date Purpose Remarks
2023-05-26 Audited Results
2022-11-11 Quarterly Results

Nidan Laboratories And Healthcare FAQs

What is Share Price of Nidan Laboratories And Healthcare ?

Nidan Laboratories And Healthcare share price is ₹42 As on 28 May, 2023 | 11:05

What is the Market Cap of Nidan Laboratories And Healthcare ?

The Market Cap of Nidan Laboratories And Healthcare is ₹58.6 Cr As on 28 May, 2023 | 11:05

What is the P/E ratio of Nidan Laboratories And Healthcare ?

The P/E ratio of Nidan Laboratories And Healthcare is As on 28 May, 2023 | 11:05

What is the PB ratio of Nidan Laboratories And Healthcare ?

The PB ratio of Nidan Laboratories And Healthcare is 0.9 As on 28 May, 2023 | 11:05

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number